Your account is not claimed yet. You can sign up with ORCID to claim your account.

Nazanin Zounemat Kermani (Nazanin Kermani, Nazanin Z Kermani)

Years Active: 2020-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Ji-Hyang Lee, Piers Dixey, Pankaj K Bhavsar, Katie Raby, Nazanin Zounemat Kermani, Marc Chadeau-Hyam, Ian M Adcock, Heung-Woo Park, Hyouk-Soo Kwon, Sei-Won Lee, You-Sook Cho, Kian Fan Chung, Tae Bum Kim
Precision Medicine Intervention in Severe Asthma (PRISM) study: molecular phenotyping of patients with severe asthma and response to biologics. ERJ open research 9 (2) (2023)
Sharon Mumby, Nazanin Zounemat Kermani, James P Garnett, Stelios Pavlidis, Susan J Wilson, Peter J Howarth, Matthew J Thomas, Ian M Adcock, Carlos Lopez-Garcia
CEACAM5 is an IL-13-regulated epithelial gene that mediates transcription in type-2 (T2) high severe asthma. Allergy 77 (11) (2022)
Md Khadem Ali, Richard Y Kim, Alexandra C Brown, Jemma R Mayall, Rafia Karim, James W Pinkerton, Gang Liu, Kristy L Martin, Malcolm R Starkey, Amber L Pillar, Chantal Donovan, Prabuddha S Pathinayake, Olivia R Carroll, Debbie Trinder, Hock L Tay, Yusef E Badi, Nazanin Zounemat Kermani, Yi-Ke Guo, Ritambhara Aryal, Sharon Mumby, Stelios Pavlidis, Ian M Adcock, Jessica Weaver, Dikaia Xenaki, Brian G Oliver, Elizabeth G Holliday, Paul S Foster, Peter A B Wark, Daniel M Johnstone, Elizabeth A Milward, Philip M Hansbro, Jay C Horvat
Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma. The European respiratory journal 55 (4) (2020)

Nazanin Zounemat Kermani.css-eqlu8i{font-size:small;padding-left:4px;} (Nazanin Kermani, Nazanin Z Kermani)